or Try an Advanced Search...

    Technical Analysis for ACET - Adicet Bio, Inc.

    Grade Last Price % Change Price Change
    F 1.25 -2.34% -0.03
    ACET closed down 2.34 percent on Friday, November 1, 2024, on 61 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    Earnings due: Nov 6
    *** please verify all earnings dates ***
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical ACET trend table...
    Date Alert Name Type % Chg
    Lower Bollinger Band Walk Weakness 0.00%
    Below Lower BB Weakness 0.00%
    Down 3 Days in a Row Weakness 0.00%
    Down 4 Days in a Row Weakness 0.00%
    Lower Bollinger Band Touch Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    Expansion Breakdown Bearish Swing Setup -2.34%
    Stochastic Reached Oversold Weakness -2.34%
    Below Lower BB Weakness -2.34%
    Down 3 Days in a Row Weakness -2.34%
    Older End-of-Day Signals for ACET ...

       Recent Intraday Alerts

    Alert Time
    Fell Below Previous Day's Low about 20 hours ago
    Down 2 % about 20 hours ago
    60 Minute Opening Range Breakdown about 23 hours ago
    Down 1% about 23 hours ago
    1.5x Volume Pace about 23 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    ACET Chart by TradingView
    Basic chart:

    Profile

    Adicet Bio, Inc. is a biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Adicet is advancing a pipeline of “off-the-shelf” gamma delta T cells, engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and improve persistence for durable activity in patients.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Biotechnology Cancer Clinical Medicine Disease Immune System Antibodies Cancer Immunotherapy Chimeric Antigen Receptor T Cell Therapies For Cancer T Cell Chimeric Antigen Receptor Adoptive Cell Transfer Antigen Immune Response

    Is ACET a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Oct 17 Adicet Bio Advances FDA-Approved Autoimmune Therapy Trials
    Oct 16 Adicet Bio gets FDA clearance of IND amendment for stiff person syndrome treatment
    Oct 16 Adicet Bio Announces FDA Clearance of IND Amendment to Evaluate ADI-001 in Idiopathic Inflammatory Myopathy and Stiff Person Syndrome
    Sep 30 Adicet Bio to Present at the American Society of Gene & Cell Therapy’s (ASGCT) 2024 Advancing Gene + Cell Therapies for Cancer Conference
    Sep 30 Adicet Opens Enrollment for ADI-001 Phase 1 Clinical Trial in Autoimmune Diseases
    Sep 19 ADI-001 Clinical Biomarker Data Demonstrate Robust Tissue Trafficking and Complete B Cell Depletion in Secondary Lymphoid Tissue
    Sep 11 Adicet Bio narrows focus on lead asset
    Aug 27 Adicet Bio to Present at the H.C. Wainwright 26th Annual Global Investment Conference
    Aug 19 Adicet Bio Appoints Lloyd Klickstein, M.D., Ph.D. to the Board of Directors
    Aug 13 Adicet Bio GAAP EPS of -$0.33
    See more ACET news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 3.7699
    52 Week Low 1.05
    Average Volume 402,805
    200-Day Moving Average 1.77
    50-Day Moving Average 1.44
    20-Day Moving Average 1.41
    10-Day Moving Average 1.40
    Average True Range 0.08
    RSI (14) 33.33
    ADX 11.92
    +DI 12.31
    -DI 23.46
    Chandelier Exit (Long, 3 ATRs) 1.30
    Chandelier Exit (Short, 3 ATRs) 1.49
    Upper Bollinger Bands 1.54
    Lower Bollinger Band 1.29
    Percent B (%b) -0.14
    BandWidth 17.88
    MACD Line -0.03
    MACD Signal Line -0.01
    MACD Histogram -0.0196
    Fundamentals Value
    Market Cap 102.56 Million
    Num Shares 82.1 Million
    EPS -3.35
    Price-to-Earnings (P/E) Ratio -0.37
    Price-to-Sales 14.00
    Price-to-Book 1.38
    PEG Ratio 0.82
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.33
    Resistance 3 (R3) 1.33 1.32 1.31
    Resistance 2 (R2) 1.32 1.30 1.31 1.31
    Resistance 1 (R1) 1.28 1.29 1.28 1.28 1.30
    Pivot Point 1.27 1.27 1.26 1.26 1.27
    Support 1 (S1) 1.23 1.25 1.23 1.23 1.20
    Support 2 (S2) 1.22 1.24 1.21 1.19
    Support 3 (S3) 1.18 1.22 1.19
    Support 4 (S4) 1.18